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Recently there has been renewed interest in CMRO2 mapping 
as a close approximation for brain work (Hyder et al., 2002). 
Positron emission tomography (PET) measures CMRO2 non-in-
vasively, but requires use of multiple radioactive tracers (Ito et al., 
2005). Magnetic resonance spectroscopy (MRS) utilizing detec-
tion of non-radioactive 17O isotope can also measure CMRO2 non-
  invasively (Zhu et al., 2009), whereas 13C MRS used in conjunction 
with different 13C-labeled substrates (e.g., glucose or acetate) can 
distinguish between energetics of neurons and astrocytes (Hyder 
et al., 2006). Both of these MRS techniques, however, have lower 
spatial resolution compared to magnetic resonance imaging (MRI) 
and PET, whereas all of these techniques have relatively poor tempo-
ral resolution. Measurements of tissue oxygen tension (pO2) can be 
used to infer local dynamics of uncoupling between oxygen delivery 
(i.e., CBF) and its subsequent utilization (i.e., CMRO2) (Ances et al., 
2001), but its invasiveness limits translation to humans.
IntroductIon
In the adult mammalian brain glucose oxidation provides major-
ity of the ATP needed to support normal function of neurons 
and astrocytes (Shulman et al., 2004). Since endogenous energy 
reserves are at μM to mM levels (Hyder, 2009), timely delivery of 
energy substrates (i.e., glucose and oxygen) from blood to sup-
port neural activity is essential (Paulson et al., 2010). Variations 
in neural activity trigger a cascade of responses that collectively 
adjust delivery of energy substrates to meet the local ATP demand 
(Riera et al., 2008). “Neurovascular coupling” relates local changes 
in neural activity and constriction/dilation of blood vessels to 
decrease/increase  cerebral  blood  flow  (CBF)  and/or  volume 
(CBV) to a region, whereas “neurometabolic coupling” relates 
focal alterations in neural activity to cerebral metabolic rate 
of  oxygen  consumption (CMRO2)  to  keep  pace  with  cellular 
ATP demand.
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Functional magnetic resonance imaging (fMRI) with blood-oxygenation level dependent (BOLD) 
contrast is an important tool for mapping brain activity. Interest in quantitative fMRI has renewed 
awareness in importance of oxidative neuroenergetics, as reflected by cerebral metabolic 
rate of oxygen consumption () , CMRO2  for supporting brain function. Relationships between 
BOLD signal and the underlying neurophysiological parameters have been elucidated to allow 
determination of dynamic changes in CMRO2 by “calibrated fMRI, ” which require multi-modal 
measurements of BOLD signal along with cerebral blood flow (CBF) and volume (CBV). But 
how do CMRO2 changes, steady-state or transient, derived from calibrated fMRI compare with 
neural activity recordings of local field potential (LFP) and/or multi-unit activity (MUA)? Here 
we discuss recent findings primarily from animal studies which allow high magnetic fields 
studies for superior BOLD sensitivity as well as multi-modal CBV and CBF measurements 
in conjunction with LFP and MUA recordings from activated sites. A key observation is that 
while relationships between neural activity and sensory stimulus features range from linear 
to non-linear, associations between hyperemic components (BOLD, CBF , CBV) and neural 
activity (LFP , MUA) are almost always linear. More importantly, the results demonstrate good 
agreement between the changes in CMRO2 and independent measures of LFP or MUA. The 
tight neurovascular and neurometabolic couplings, observed from steady-state conditions to 
events separated by <200 ms, suggest rapid oxygen equilibration between blood and tissue 
pools and thus calibrated fMRI at high magnetic fields can provide high spatiotemporal mapping 
of CMRO2 changes.
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Because  functional  MRI  (fMRI)  has  good  spatiotemporal 
resolution and allows non-invasive imaging of almost the entire 
brain, it has great translational possibilities (Matthews et al., 2006). 
The blood-oxygenation level dependent (BOLD) signal, however, 
reports indirectly on neural activity because it measures the hyper-
emic response (Ogawa et al., 1993). But it is feasible to calculate 
CMRO2 from the BOLD signal (S) provided that it is calibrated by 
combining CBF and CBV measurements (Hoge and Pike, 2001; 
Hyder et al., 2001) according to the relationship
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The basis for ∆CMRO2 mapping with “calibrated fMRI” is that it 
reflects the oxidative ATP demanded for neural work (Davis et al., 
1998; Hoge et al., 1999). Recent non-human studies report that 
magnitudes of ∆CMRO2 derived from calibrated fMRI are com-
mensurate with changes in neural firing under steady-state condi-
tions (Smith et al., 2002; Kida et al., 2006; Maandag et al., 2007). 
However both the neurovascular and neurometabolic couplings 
remain to be established for Eq. 1.
The first and second terms on the right-hand side of Eq. 1 reflect 
changes in oxygenation and volume, respectively, where for ∆S/S > 0 
the first term has to exceed the second term. Because arterial blood is 
almost fully oxygenated, functional hyperemia – and thus, by infer-
ence, BOLD signal – manifests oxygenation and volume changes 
primarily at the venous end (Hoge and Pike, 2001; Hyder et al., 
2001). Although magnitudes of the two terms on the right-hand 
side of Eq. 1 are typically on the order of 0.1–0.2 for functional 
studies (Hoge and Pike, 2001; Hyder et al., 2001), the metabolic 
(C MR CMR OO ∆
22 /)  and hemodynamic (∆CBF/CBF) factors which 
together contribute to the first term can be much larger.
For increased oxygenation ∆CBF/CBF has to be greater than 
∆CMRC MR OO 22 /.  Because increased blood oxygenation is propor-
tional to decreased tissue oxygen extraction at steady-state accord-
ing to Fick’s principle, an embedded assumption in ∆CMRO2 time 
courses derived from calibrated fMRI is that oxygen is equilibrated 
between blood and tissue pools (Hyder et al., 1998). To date, steady-
state assumptions of Eq. 1 are extended into the dynamic regime 
without  experimental  evidence  of  rapid  oxygen  equilibration 
between blood and tissue pools. For dynamic ∆CMRO2 modeling 
from calibrated fMRI, both neurometabolic and neurovascular 
couplings have to be examined to establish if the same linearity 
of terms in Eq. 1 vs. neural activity can be used for event-related 
paradigms all the way up to block-design paradigms.
The second term of Eq. 1, which reflects changes in venous 
blood volume (∆CBV/CBV), is typically much smaller than changes 
in the metabolic (/ ) ∆CMRC MR OO 22  and hemodynamic (∆CBF/
CBF) terms (Hoge and Pike, 2001; Hyder et al., 2001). Despite 
the small magnitude of this term, independent measurement is 
important because its dynamic evolution is significantly different 
from measured time courses of CBF and BOLD signal (Kida et al., 
2007; Shen et al., 2008). In non-human studies ∆CBV is usually 
measured independently (Hyder et al., 2001), whereas in human 
studies ∆CBV is usually estimated from an assumed relationship 
with ∆CBF (Hoge and Pike, 2001). To date, changes in hematocrit 
are either neglected and/or lumped into the second term (Hyder 
et al., 2001), an assumption which needs further testing (Herman 
et al., 2009b).
The parameter A in Eq. 1, as originally described by Ogawa 
et al. (1993) in describing the BOLD model (and similar to the 
parameter M in other calibrated fMRI reports; see Hoge and Pike, 
2001 for details), is a magnetic field dependent constant. It has 
been reported to be 0.1–0.2 for gray matter at 1.5T and 0.3–0.4 
at 7.0T, respectively, where human and animal calibrated fMRI 
studies are typically conducted (Hoge and Pike, 2001; Hyder et al., 
2001). Because the parameter A (or M) may vary regionally, and 
also depends on the echo time used in gradient-echo or spin-echo 
fMRI experiments, independent measurements are required for 
different experimental conditions (Chiarelli et al., 2007; Leontiev 
et al., 2007; Ances et al., 2009b).
Early calibrated fMRI studies, both in humans (Davis et al., 1998; 
Kim et al., 1999; Hoge and Pike, 2001; Restom et al., 2008; Ances 
et al., 2009a) and animals (Kida et al., 1999, 2000; Hyder et al., 
2001; Shen et al., 2008), focused on high resolution ∆CMRO2 maps. 
Because neural activity measurements were not available, these 
reports excluded assessment of neurovascular and neurometabolic 
couplings which are embedded in the interpretation of calibrated 
fMRI results. A critical issue in estimating ∆CMRO2 derived from 
calibrated fMRI to represent changes in neural activity, especially 
in a dynamic manner, is whether changes in oxygen extraction 
affect the observed neurovascular and neurometabolic couplings 
differently  for  transient  and  steady-state  events.  This  issue  is 
particularly important for calculating the temporal evolution of 
CMRO2 with dynamic calibrated fMRI because it is unclear whether 
couplings of the different parameters in Eq. 1 vs. neural activity 
can be assumed to be the same for event-related and block-design 
paradigms. To address this unresolved issue in the interpretation 
of calibrated fMRI results, we conducted calibrated fMRI studies 
at high magnetic field (11.7T) for superior BOLD sensitivity and 
included extracellular measurements of local field potential (LFP) 
and multi-unit activity (MUA) from the activated sites. Our find-
ings lend confidence in the measurement of CMRO2 transients with 
dynamic calibrated fMRI at high magnetic fields (Herman et al., 
2009a; Sanganahalli et al., 2009).
MultI-Modal Methods for calIbrated fMrI and 
neural actIvIty
Today, MRI can be used to measure CBF, CBV, and the BOLD signal 
in the same session with relatively high spatiotemporal resolution 
(Kida and Hyder, 2006). Of these methods, BOLD is the easiest 
to implement and apply because it requires no exogenous MRI 
contrast agent. CBV requires an exogenous MRI contrast agent, 
whereas CBF needs additional radio frequency (RF) hardware to 
selectively label arterial blood water. The temporal resolution of 
BOLD and CBV can be increased with marginal sensitivity losses 
(Kida et al., 2007; Shen et al., 2008), but dynamic measurements of 
CBF experience significant loss in signal-to-noise ratio (SNR) with 
fast imaging (Silva and Kim, 1999; Kida et al., 2004). Each method 
is generally believed to have superior SNR at higher magnetic field 
strengths, whereas the intravascular component of BOLD signal is 
reduced at higher magnetic fields (Ugurbil et al., 2000).Frontiers in Neuroenergetics  www.frontiersin.org  August 2010  | Volume 2  | Article 18  |  3
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to estimate this component from measured CBF changes, where 
CBV = CBFφ. While a high Φ value (e.g., 0.4 as in Grubb’s original 
observation with hypercapnia challenge in primates; Grubb et al., 
1974) has been typically assumed in some calibrated fMRI studies 
(Davis et al., 1998; Hoge et al., 1999; Chiarelli et al., 2007; Leontiev 
et al., 2007; Ances et al., 2009b), measured Φ values during func-
tional activation are typically much smaller (Kida et al., 2007; Jin 
and Kim, 2008; Shen et al., 2008).
To estimate ∆CMRO2 from calibrated fMRI in relation to dynamic 
changes in neural activity, it is necessary to examine neurovascular 
and neurometabolic couplings for transient and steady-state events. 
If oxygen equilibrates rapidly between blood and tissue pools, then 
the same linearity of terms in Eq. 1 vs. neural activity can be used for 
event-related paradigms all the way up to block-design paradigms. 
Thus, for event-related and block-design paradigms, we measured 
high SNR hyperemic (BOLD, CBV, CBF) responses from the rat 
somatosensory cortex and related these imaging signals to neural 
activity (LFP, MUA) (Figure 1). The forepaw stimulation model 
in the α-chloralose anesthetized rat is extensively used because the 
time-dependent stimulus parameters (duration, frequency, etc.) 
can be easily and reproducibly manipulated (Van Camp et al., 
2006; Sanganahalli et al., 2008) to compare activation responses in 
a dynamic manner (Herman et al., 2009a; Sanganahalli et al., 2009). 
To examine dynamic variations of neurometabolic and neurovascu-
lar couplings both the number of stimulus pulses (i.e., single event 
to steady-state) and the stimulus interval between pulses (i.e., low 
to high frequency) were varied. Because the ASL measurement of 
CBF dynamics lacks sensitivity compared with the BOLD and CBV 
measurements, we employed laser-Doppler flowmetry to measure 
red blood cell flux (Silva and Kim, 1999; Kida et al., 2004) and which 
can be easily combined with electrical measurements in rat brain 
(Trubel et al., 2006; Schridde et al., 2008).
In our laboratory we use a dual-sensor device consisting of 
adjacent but isolated electrical and optical probes to simultane-
ously measure neural and CBF signals, respectively (Herman 
Oxyhemoglobin is diamagnetic and deoxyhemoglobin is para-
magnetic, allowing BOLD image-contrast to be generated by con-
ventional spin-echo or gradient-echo images which are sensitive 
to magnetic properties of blood (Kennan et al., 1994; Weisskoff 
et al., 1994). Deoxyhemoglobin in blood behaves as an endogenous 
MRI contrast agent, creating local magnetic field gradients which 
extend into the surrounding tissue and dephase magnetization of 
tissue water protons. Local gradients outside blood vessels enhance 
dephasing of tissue water protons which is detected by decreased 
signals in both spin-echo or gradient-echo images due to attenua-
tion of transverse relaxation rates of tissue water protons (1/T2).
The CBV image-contrast by MRI is similar to BOLD in the 
sense that it is also based on magnetic susceptibility (Kennan et al., 
1998; Mandeville et al., 1998). In non-human subjects changes in 
CBV are usually measured by utilizing plasma-borne intravascular 
paramagnetic MRI contrast agents, which are nanoparticles com-
posed of oxides of iron or other metals, that affect the transverse 
relaxation rates of tissue water protons. If the MRI contrast agent 
is uniformly distributed in the vascular system and has a long half-
life of elimination, then changes in spin-echo or gradient-echo 
images acquired before and after the MRI agent injection can be 
interpreted straightforwardly as CBV changes within the entire 
vascular network (CBVt).
However, because the volume term in Eq. 1 is localized to the 
venous compartment (CBVv) the use of ∆CBVt in place of ∆CBVv 
in Eq. 1 may over represent contributions of the volume term to 
some extent, thus causing a slight underestimation of ∆CMRO2 
from calibrated fMRI. Using slightly different MRI methods to 
separate arterial (CBVa) and venous (CBVv) compartments (Kim 
and Kim, 2005), recent studies in non-human subjects show that 
changes in CBVa may dominate (Kim et al., 2007). However it is 
yet unclear how to incorporate changes of ∆CBVa vs. ∆CBVv into 
Eq. 1 for calibrated fMRI.
The CBF sensitivity by MRI is achieved by arterial spin labeling 
(ASL), where magnetic labeling by RF pulses of flowing spins in 
arterial blood water (e.g., by inversion or saturation) functions 
as an endogenous tracer (Detre et al., 1992; Williams et al., 1992). 
The labeled spins of blood water mix with unlabeled station-
ary spins of tissue water to attenuate the apparent longitudinal 
relaxation time of tissue water. Although ASL techniques suffer 
from poor temporal resolution because of the waiting period 
required for exchange of labeled and unlabeled spins, alternative 
labeling methods can be used to improve CBF temporal resolu-
tion, albeit with some sensitivity losses (Silva and Kim, 1999; 
Kida et al., 2004).
∆CMRO2 estimated from calibrated fMRI requires measurements 
of BOLD signal, CBF, and CBV in the same subject and preferably 
in the same session. BOLD and CBF methods do not differ when 
applied to human and non-human subjects. However CBV meth-
ods vary significantly between human (e.g., see Stefanovic and Pike, 
2005) and non-human (e.g., see Lu et al., 2005) subjects because 
MRI contrast agents cannot be repeatedly injected into humans. 
When changes in BOLD signal, CBF, and CBV are measured in the 
same session in non-human subjects, CBV is measured last because 
injection of the MRI contrast agent affects the other imaging sig-
nals. Because of difficulties with the CBV measurement in human 
subjects, Grubb’s relationship (Grubb et al., 1974) is usually used 
Figure 1 | Single trial multi-modal data. Representative neural [(A); LFP] 
and imaging [(B–D); BOLD, CBV, CBF] signals for short forepaw stimuli 
(vertical bars). While there was an evoked LFP for each stimulus pulse, 
alternate LFP’s were not identical. A similar trend was observed for MUA (data 
not shown). Modified from results published in Herman et al. (2009a).Frontiers in Neuroenergetics  www.frontiersin.org  August 2010  | Volume 2  | Article 18  |  4
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relatIonshIp between neural and  
hypereMIc responses
Trends of electrophysiological recordings of LFP and MUA from the 
contralateral somatosensory cortex averaged across six subjects are 
shown in Figure 2A. The patterns of the LFP and MUA data were 
generally similar and in both cases the evoked neural responses 
to multiple stimuli were normalized to the response of the first 
stimulus pulse. At the lowest stimulation frequency of 1.5 Hz, each 
evoked neural response for individual stimulus pulses was quite 
similar to the prior ones with minimal neural response attenuation 
for additional stimulus pulses.
In contrast, at the highest stimulation frequency of 6.0 Hz there 
were small or negligible evoked neural responses detected for multi-
ple stimulus pulses (i.e., there was mainly one large evoked response 
with the first stimulus pulse). For the intermediate stimulus fre-
quency of 3.0 Hz, alternate evoked neural responses to subsequent 
stimulus pulses were significantly attenuated compared to the neu-
ral response of the previous stimulus pulse. Stimulus frequency 
dependent variations in neural activity are consistent with studies 
using various anesthetics (Nemoto et al., 2004; Ureshi et al., 2004) 
including α-chloralose (Matsuura and Kanno, 2001; Sheth et al., 
2004). In summary, at a stimulus frequency of 6.0 Hz increas-
ing the stimulus number changed the evoked response very little 
(from the response with a single stimulus pulse), whereas at lower 
stimulus frequencies increasing the stimulus number augmented 
the evoked responses linearly (Herman et al., 2009a; Sanganahalli 
et al., 2009).
Trends of hyperemic responses (BOLD, CBV, CBF) from the 
contralateral somatosensory cortex averaged across eight subjects 
are shown in Figures 2B–D. Although the BOLD, CBV, and CBF 
data generally behaved similarly (e.g., augmentation with higher 
stimulus number or attenuation with higher stimulus frequency), 
the temporal patterns of each varied indicating their dissimilar 
physiologic origins. Both the intensity and width of each hyperemic 
response augmented with increasing stimulus number (Herman 
et al., 2009a; Sanganahalli et al., 2009). For stimulus frequencies of 
1.5 and 3.0 Hz, the hyperemic response grew linearly with increas-
ing number of stimulus pulses, whereas for the same number of 
stimulus pulses the hyperemic response decreased with higher 
stimulus frequency (Herman et al., 2009a; Sanganahalli et al., 2009). 
At stimulus frequencies of 1.5 and 3.0 Hz, enhancement of the 
response with increase in stimulus number is correlated with the 
increase in neural activity. For a stimulus frequency of 6.0 Hz, the 
responses were nearly identical for different numbers of stimulus 
pulses, similar to the neural data.
Each hyperemic response was measured with respect to the 
pre-stimulus baseline. The mean time-to-peak in BOLD responses 
was  ∼3.9  s,  peaking  at  ∼8%,  ∼5%,  and  ∼4%,  respectively,  for 
stimulation frequencies of 1.5, 3.0, and 6.0 Hz. This is due to the 
stimulus frequency tuning responses under α-chloralose anesthe-
sia (Sanganahalli et al., 2008). The mean time-to-peak in CBV 
responses was ∼3.3 s, peaking at 11%, 10%, and 4%, respectively, 
for stimulation frequencies of 1.5, 3.0, and 6.0 Hz. Optical stud-
ies using the combination of oxy- and deoxyhemoglobin signals 
to estimate CBV changes demonstrate similar dependencies with 
variations in stimulus frequency and duration (Sheth et al., 2003; 
Nemoto et al., 2004). The mean time-to-peak in CBF responses 
et al., 2009a; Sanganahalli et al., 2009). LFP and MUA, meas-
ured  simultaneously  with  a  high  impedance  microelectrode 
(>2 MΩ), are obtained by splitting the extracellular signal into 
low (<150 Hz) and high (0.4–10 kHz) frequency bands. Laser-
Doppler signals are measured with respect to the pre-stimulus 
baseline, where the intensity of the optical signal (with 3 Hz 
forepaw stimulation) was calibrated to CBF data collected with 
the ASL technique (3 Hz, 2 mA, 0.3 ms, 96 pulses) as previously 
described (Kida et al., 2004). The high temporal resolution neu-
ral signals were integrated into 0.02 s running bins (equivalent 
to 50 Hz sampling of the laser-Doppler signal for CBF) allow-
ing comparison with the lower temporal resolution BOLD and 
CBV data. All fMRI data were obtained on an 11.7T horizontal-
bore spectrometer using a 1H surface coil RF probe and high 
SNR gradient-echo contrast pulse sequence with repetition and 
echo time of 1000 and 15 ms, respectively (Herman et al., 2009a; 
Sanganahalli et al., 2009).
The basis of using calibrated fMRI to represent neuronal tran-
sients with dynamic ∆CMRO2 is to test the temporal relationships 
between hyperemic components (BOLD, CBV, CBF) and neural 
activity (LFP, MUA), both for transient and steady-state events. If 
these relationships are linear within the stimuli ranges examined, 
then the respective transfer functions (of BOLD, CBV, CBF) would 
be considered time invariant (Boynton et al., 1996; Ances et al., 
2000). Convolution theory states that the input signal, i(t), when 
convolved with a transfer function, h(t), produces an output signal, 
r(t). In our experiments we measure both i(t) and r(t) with high spa-
tiotemporal resolution (Herman et al., 2009a; Sanganahalli et al., 
2009). LFP or MUA were used as the neural signal, whereas BOLD, 
CBV, and CBF represented the independent hyperemic responses. 
The transfer function, h(t), can be achieved by a deconvolution 
between r(t ) and i( t ). If the frequency domain representations of 
i(t), r(t), and h(t) are given by I(ω), R(ω), and H(ω), respectively, 
then it can be shown that:
it ht rt
IHR
() () ()
() () ()
⊗=
×= ωωω  
(2)
where t and ω are time and frequency domains, respectively, and 
inverse Fourier transform of H(ω) gives h(t). The gamma vari-
ate function is widely used for transfer function modeling. We 
used a slightly different form of the original equation (Madsen, 
1992) so that the fitting parameters are independent from each 
other (Herman et al., 2009a; Sanganahalli et al., 2009). To find 
the best applicable transfer function we used a least-square 
mean  Gauss–Newton  fitting  method  which  has  three  steps: 
(i) a transfer function is created with initial parameters; (ii) a 
transfer function is convolved with the input; (iii) a residual 
signal is created by differencing the predicted and measured 
signals. If the predicted signal is significantly different from the 
measured signal, then the parameters of the transfer function 
are changed and the process is continued from the first step. 
The fitting process is typically completed within a few hundred 
iterations and the last applied parameters are used to define the 
transfer function. Residuals are found acceptable if all of their 
values are within the range of uncertainty of the corresponding 
measured signal, as represented by the standard deviation (SD) 
about the mean.Frontiers in Neuroenergetics  www.frontiersin.org  August 2010  | Volume 2  | Article 18  |  5
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  stimulation frequencies of 1.5 and 3.0 Hz). Because the compari-
sons in Figure 3 are of signal integrals (i.e., intensity and width) 
between  the  hyperemic  components  (BOLD,  CBV,  CBF)  and 
neural activity (LFP, MUA) – which occur over quite dissimilar 
time scales (e.g., see Figure 1) – the intercepts on the vertical 
and horizontal axes are slightly different. While these findings are 
generally consistent with other reports (Sheth et al., 2004; Ureshi 
et al., 2004; Van Camp et al., 2006), the current results are unique 
in that the relationship for all components of neurovascular and 
neurometabolic couplings were investigated for very small tem-
poral changes of the stimuli.
cMro2 transIents wIth dynaMIc calIbrated fMrI
We used convolution analysis to find a transfer function that 
connects the neural signal to each hyperemic component, the 
effectiveness of which was characterized by the residual signal 
as given by the difference between the measured and predicted 
signals. If temporal fluctuations of the residual signal were smaller 
than the uncertainty of the measured signal over time (i.e., SD of 
the experimental measurement), the convolution process would 
produce a universal impulse response function. This is extremely 
was ∼3 s, peaking at ∼100%, ∼101%, and ∼53%, respectively, for 
  stimulation   frequencies of 1.5, 3.0, and 6.0 Hz. Our observation 
of the CBF trends with variations in stimulus duration and fre-
quency is in agreement with prior observations (Ances et al., 2000; 
Martindale et al., 2003). The time course of cessation of the hyper-
emic response was different for each modality, with CBV having 
the slowest decay to pre-stimulation baseline values. Generally, the 
characteristics of CBF responses (intensity, width) were similar to 
the BOLD and CBV data, but with some caveats. For example, the 
non-linearity of the CBF response (vs. stimulus number with dif-
ferent stimulus frequency) was different than that observed with 
BOLD or CBV.
Since each signal is a function of varying amplitude over time, 
we measured response strength as the integral of the signal over 
the entire neural and hyperemic responses (Figure 3). We plot-
ted normalized responses to quantify the relationships between 
hyperemic components (BOLD, CBV, CBF) and neural activity 
(LFP, MUA). Since neural and hyperemic signals at stimulus fre-
quency of 6 Hz showed very little change with increasing stimulus 
number, this analysis was omitted here. Figures 3A,B show the 
relationships between LFP and MUA vs. hyperemic responses (at 
Figure 2 | Neural and hyperemic responses to varying transient stimuli. 
LFP (A) simultaneously recorded with MUA (data not shown) from the 
contralateral somatosensory cortex. Responses to subsequent stimuli were 
normalized to the response of the first stimulus pulse. At stimulation 
frequency of 1.5 Hz, each evoked response for individual stimulus pulses was 
quite similar to the prior ones. At stimulation frequency of 3.0 Hz, alternate 
responses to subsequent stimuli were significantly attenuated compared to 
the response of the first stimulus pulse. At stimulation frequency of 6.0 Hz, 
the responses to subsequent stimuli were significantly attenuated. As the 
number of stimulus pulses increased, the responses were augmented for 
stimulation frequencies of 1.5 and 3.0 Hz but not for 6.0 Hz (data not shown). 
BOLD (B), CBV (C), and CBF (D) recorded from the contralateral 
somatosensory cortex. The CBF data were obtained simultaneously with the 
LFP (and MUA) data. In correspondence with the neural data, as stimulation 
frequency increased the hyperemic responses became attenuated. However 
the degree of attenuation was different for each modality. The vertical bars 
represent the stimuli ± SD from the mean. All data shown for three stimulus 
pulses indicated by red vertical bars. Neural and hyperemic traces are in 4 and 
40 s duration, respectively. Modified from results published in Sanganahalli 
et al. (2009).Frontiers in Neuroenergetics  www.frontiersin.org  August 2010  | Volume 2  | Article 18  |  6
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and CBF are in good agreement with literature reports. Since a 
detailed discussion of each transfer function is not the goal here, 
the general observations are as follows: the CBF impulse peaks the 
earliest whereas the BOLD and CBF impulses are different in shape 
compared to the CBV impulse which has a very long tail.
While results from prior studies are insightful about convolu-
tion theory, they should be interpreted with caution because of 
the use of an interpolation procedure between consecutive evoked 
neural signals (Ances et al., 2000; Mathiesen et al., 2000), whereas 
we used the signal strength. Interpolating between separate neural 
events creates the impression of a more weighted neural signal. 
For long stimulus durations this process may have minimal impact 
on deconvolution because smoothing changes the signal envelope 
(or shape) very little. In contrast, however, for brief stimuli this 
approach could generate non-linearity from deconvolution because 
smoothing creates a signal that is quite different from the actual 
response. In our studies, treatment of each evoked neural response 
was a key feature utilized in both linearity assessments across dif-
ferent measurements and demonstration of the time invariance of 
the transfer functions.
Demonstration of time invariance of the transfer function was 
based on two different systematic comparisons of the predicted 
and measured signals (Herman et al., 2009a; Sanganahalli et al., 
2009). In one comparison, the root-mean-square (RMS) of the 
residual signal was compared with the SD of the   measurement. 
important as it suggests that the respective transfer function should 
be time invariant within the temporal regime of the stimulus 
parameters.
We parameterized the transfer function with a gamma variate 
for each hyperemic component (Herman et al., 2009a; Sanganahalli 
et al., 2009). Briefly, the transfer functions generated by convolution 
analysis with LFP and MUA were quite similar in shape and the 
time-to-peak for BOLD, CBV, and CBF impulses were ∼2.6, ∼2.1, 
and ∼1.8 s, respectively. The systematic difference between the time-
to-peak of each measured response and each transfer function is 
consistent with prior observations (Ances et al., 2000; Buracas and 
Boynton, 2002; Silva et al., 2007), but prior studies did not include 
neural data or used interpolated neural data for deconvolution. We 
used the strength of the neural data to specifically target the delicate 
non-linear trends of neural data over time and their impact on the 
impulse response function.
Past studies applied convolution analysis with the BOLD response 
to report either linearity (Boynton et al., 1996) or non-linearity 
(Vazquez and Noll, 1998), but these studies used the stimulus itself 
as the input due to lack of neural activity recordings. Recent studies 
which include neural activity measurements reveal specific trends 
that agree with our observations (Matsuura and Kanno, 2001; Sheth 
et al., 2004), but only a few have applied convolution analysis with 
CBF and CBV (Ances et al., 2001; Martin et al., 2006; Silva et al., 
2007). In general, the transfer functions generated for BOLD, CBV, 
Figure 3 | relationships between multi-modal imaging signals vs. LFP 
(A) and MUA (B). For a stimulus frequency of 6.0 Hz the hyperemic 
responses changed minimally with increasing number of stimulus pulses 
(data not shown), whereas linear trends were observed for stimulus 
frequencies of 1.5 Hz (O) and 3.0 Hz (∆). These linear trends resulted in 
universal transfer functions for each of the hyperemic responses. For each 
signal type (i.e., BOLD, CBV, CBF), because the same transfer function was 
successfully able to simulate the raw signal for various temporal events, the 
results and their analysis verified that the measured hyperemic responses 
were linear for the applied stimuli. All of the transfer functions were described 
with one (BOLD, CBF) or two (CBV) gamma variate functions. The scale of the 
CBF transfer function was a magnitude greater than the other transfer 
functions. CBF h(t) peaks the earliest (1.83 s), whereas BOLD h(t) peaks the 
latest (2.57 s). Both of these transfer functions have shorter tails to reach 
baselines (within ∼4 and ∼8 s, respectively, after peaking), whereas CBV h(t) 
has a very long tail (requiring ∼1 min to reach baseline). CBV h(t) peaks about 
the same time as the CBF h(t) (2.16 s). Modified from results published in 
Sanganahalli et al. (2009) and Herman et al. (2009a).Frontiers in Neuroenergetics  www.frontiersin.org  August 2010  | Volume 2  | Article 18  |  7
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A in Eq. 1, which is expected based on prior observations of 
rat cerebral cortex at magnetic fields higher than 7.0T (Kida 
et al., 1999, 2000; Hyder et al., 2001; Englot et al., 2008; Schridde 
et al., 2008).
Relaxation measurements in different brain regions suggest that 
the T2 nearly halves from 4.0T to 11.7T (de Graaf et al., 2006) – from 
about 65 ms to about 35 ms – thereby suggesting that the A value 
in Eq. 1 may vary significantly at lower and higher magnetic fields. 
Using the data acquired at 11.7T, when the A value is halved from 
0.5 then the ∆CMRO2 is reduced by nearly the same magnitude, 
whereas when the A value is doubled from 0.5 then the ∆CMRO2 
is only marginally increased. Employing a lower value for A (e.g., 
0.10–0.15, gray matter at 1.5T) with the current 11.7T data leads 
to a reduction in ∆CMRO2 to a very low values, which would be in 
clear disagreement with steady-state 13C MRS data for the same rat 
model where significant changes in CMRO2 have been reported with 
forepaw stimulation (Hyder et al., 1996, 2000). Furthermore, the 
energetic changes measured with 13C MRS are in agreement with 
neural firing at steady-state (Smith et al., 2002; Kida et al., 2006; 
Maandag et al., 2007).
The RMS of the residual signal was averaged across the entire 
data set and compared with the average of the measurement SD 
over the same duration. In each case, the comparison showed 
that the residual “noise” in modeling was smaller than the meas-
urement uncertainty. In another comparison, only the hyper-
emic phase (i.e., the first 10 s of data after stimulation onset) 
was compared. This representation, similar to the RMS vs. SD 
comparison, showed that the predicted and measured signals were 
well correlated in each case, thereby suggesting time invariance 
of transfer functions.
The electrical and imaging data (Figure 2) revealed linear 
relationships between neural activity and each of the hyperemic 
components (Figure 3). A comprehensive convolution analysis 
revealed that the respective transfer functions (of BOLD, CBV, 
CBF) are time invariant for extremely brief events (separated 
by less than 200 ms) and all the way up to steady-state events 
(Herman et al., 2009a; Sanganahalli et al., 2009). These results 
enable calibrated fMRI to be utilized in a dynamic manner for 
calculating CMRO2 transients (Figure 4, upper panel). To estimate 
∆CMRO2 from our multi-modal data we used a value of 0.5 for 
Figure 4 | Dynamic calibrated fMri. CMRO2 dynamics (top) and 
relationships with neural (middle) and hemodynamic (bottom) responses. 
Time courses of CMRO2 responses (top) from the contralateral somatosensory 
cortex during variation of stimulation frequency (with three stimulus pulses 
indicated by red vertical bars). In correspondence with the neural data, as 
stimulation frequency increased the energetic responses were attenuated. 
For stimulus frequencies of 1.5 and 3.0 Hz the energetic responses increased 
linearly with higher number of stimulus pulses, whereas for stimulus 
frequency of 6.0 Hz the energetic responses were nearly identical for 
different number of stimulus pulses (data not shown). Each trace is 40 s in 
duration. CMRO2 values were calculated using Eq. 1. Relationships between 
CMRO2 vs. neural (middle) and CMRO2 vs. hemodynamic (bottom) data. 
Modified from results published in Sanganahalli et al. (2009) and Herman 
et al. (2009a).Frontiers in Neuroenergetics  www.frontiersin.org  August 2010  | Volume 2  | Article 18  |  8
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  frequencies  tested.  Therefore,  the  linear  relationships  between 
CMRO2 vs. neural activity depicted in Figure 4 (middle panel) sug-
gest that the coupled pre-synaptic and post-synaptic activities cor-
responding to the forepaw stimuli are roughly equally weighted 
for the rat somatosensory cortex, which is in good agreement with 
theoretical predictions (Attwell and Laughlin, 2001).  Moreover, 
the commonality of relationships between hyperemic components 
(BOLD, CBV, CBF) and neural activity (LFP, MUA), with either LFP 
or MUA, depicted in Figure 3 using the signal strength (not the signal 
amplitude) in each case suggests that LFP and MUA are equally well 
correlated with the neuroimaging signals. This finding in rat brain 
(Herman et al., 2009a; Sanganahalli et al., 2009) stands in contrast 
to prior findings in primate brain (Logothetis et al., 2001).
The impacts of CB V and CBF on the calculated values of CMRO2 
(Eq. 1) are important because they have different dynamic rela-
tionships to the BOLD signal (Figure 2). The Grubb relationship 
(Grubb et al., 1974), defined as CBV = CBFφ, shows that the value 
of the exponent,Φ as calculated for the entire hyperemic phase 
was approximately 0.15 (Figure 4, lower left panel). This value is 
in close agreement with recent animal studies (Jin and Kim, 2008; 
Shen et al., 2008) but is far smaller than what is typically assumed 
in human calibrated fMRI experiments (Davis et al., 1998; Hoge 
et al., 1999). However, we note that the value of Φ was allowed to 
vary over time for the dynamic CMRO2 calculation (Kida et al., 
2007). A tight CBF–CMRO2 dynamic coupling, ranging between 
3:2 and 5:2 (Figure 4, lower right panel), was also observed. The 
CBF–CMRO2 coupling of about 2:1 is in agreement with predic-
tions of oxygen transport models (Hyder et al., 1998; Herman et al., 
2006; Huppert et al., 2007) and results from steady-state calibrated 
fMRI studies (Hoge et al., 1999; Uludag et al., 2004; Chiarelli et al., 
2007). Although the characteristics of CBF dynamics appear to be 
quite similar to CMRO2 transients, careful examination of these two 
impulse response functions shows that oxygen delivery is fitted by 
a gamma variate (CBF), whereas oxygen use is not (CMRO2). The 
CMRO2 transfer functions were parameterized by a constrained 
non-linear half-order rational equation, where CMRO2 transients 
generated with LFP or MUA as the input were indistinguishable 
(Herman et al., 2009a; Sanganahalli et al., 2009).
lIMItatIons of dynaMIc calIbrated fMrI
To consolidate measurements from a single probe (e.g., electrical, 
optical) with high resolution fMRI data, it is important to realize 
that results pertain mainly to these focal sites. Because sampling 
from larger spatial regions with microelectrodes is not practical, 
our electrical data were confined to the middle cortical layers, which 
were then related to fMRI voxels located in similar cortical regions. 
Preliminary electrophysiology work (data not shown) suggests that 
the current results may be extended to layers above, but not neces-
sarily layers below. Moreover, these cortical results should not be 
extrapolated to sub-cortical regions without additional experimen-
tal evidence of the neurometabolic and neurovascular couplings. 
Our results provide temporal transfer functions, although studies 
are underway to obtain the spatial transfer functions which span 
the somatosensory cortex tangentially in a specific cortical layer.
An important issue for estimating ∆CMRO2 transients from 
calibrated fMRI is whether changes in oxygen extraction affect the 
observed neurovascular and neurometabolic couplings differently 
Human calibrated fMRI experiments use a brief hypercapnia chal-
lenge to estimate the A value in Eq. 1 (Davis et al., 1998; Hoge et al., 
1999). If ∆≈ CMRO2 0 is assumed with hypercapnia, then the A value 
can be estimated by measurements of BOLD signal and CBF with 
hypercapnia where CBV is assumed from CBF based on Grubb’s rela-
tionship (Grubb et al., 1974). In non-human subjects, however, the A 
value can be measured in conjunction with independent assessment 
of the CMRO2 with 13C MRS (see Shulman et al., 2002 for details), 
bypassing the need for hypercapnia (Kida et al., 2000; Hyder et al., 
2001). Measurements of BOLD signal, CBF, CBV, and CMRO2 (by 
13C MRS) at different physiological conditions allow the A value to 
be validated. This latter approach, however, is limited by the spatial 
resolution of MRS at high magnetic fields, which for the rat currently 
enables calibrated fMRI to the more homogenous cerebral cortex.
Figure 4 shows the ∆CMRO2 time courses obtained from group 
averaged data (upper panel), as well as the relationships of ∆CMRO2 
with  neural  (middle  panel)  and  hemodynamic  (lower  panel) 
responses. For stimulus frequencies of 1.5 and 3.0 Hz, the CMRO2 
response (intensity, width) increased linearly with higher number 
of stimulus pulses, whereas for the same number of stimulus pulses 
the  CMRO2 response decreased with higher stimulus frequency 
(Herman et al., 2009a; Sanganahalli et al., 2009). For a stimulus 
frequency of 6.0 Hz, the CMRO2 responses were nearly identical 
for different numbers of stimulus pulses. The mean time-to-peak 
in CMRO2 responses was ∼3.5 s, which is slightly delayed in com-
parison to CBF. CMRO2 responses for four stimulus pulses were 
largest at a stimulus frequency of 1.5 Hz (63 ± 38%) and 3.0 Hz 
(68 ± 39%), as compared to 6.0 Hz (38 ± 27%). Because existing 
pO2, PET, and other MRS methods do not provide high temporal 
resolution CMRO2 data, the good agreement between CMRO2 vs. 
neural activity (middle panel) provides the best validation available, 
although still indirect, of the use of dynamic calibrated fMRI for 
calculating ∆CMRO2 (Hyder et al., 2002).
All  hyperemic  (BOLD,  CBV,  CBF)  and  neural  (LFP,  MUA) 
relationships  used  integrated  (i.e.,  intensity  and  width)  values 
(Figure 3). Since we do not know the nominal SNR of each of 
these measured signals, it is difficult to discuss linearity or non-
linearity trends in the integral plots beyond the applied stimuli. 
Therefore linearity or non-linearity trends from these plots should 
be limited to the range of stimuli conditions examined. However 
the slightly different intercepts for hyperemic vs. neural (Figure 3) 
and CMRO2 vs. neural plots (Figure 4, middle panel) correspond 
to larger experimental error in CMRO2 prediction, which can be 
described by error propagation (Herman et al., 2009a; Sanganahalli 
et al., 2009). If we assume all hyperemic and neural signals have 
the same SNR for stimuli shorter than what we applied, it would 
suggest that CMRO2 experimental accuracy is insufficient to pre-
dict a response for such short stimuli. However it is also possible 
that CMRO2 vs. neural plot may indicate a slight non-linearity for 
shorter events than our current single event.
Overall, linear relationships were observed for CMRO2 vs. neural 
activity, with either LFP or MUA. Recent studies in primates imply 
that LFP and MUA respectively correspond to the neural input (pre-
synaptic) and output (post-synaptic) signaling (Logothetis et al., 
2001), which roughly approximates pre-synaptic and post-synaptic 
signaling. As stated earlier, LFP and MUA generally behaved   similarly 
as a function of stimulus number within the range of   stimulus Frontiers in Neuroenergetics  www.frontiersin.org  August 2010  | Volume 2  | Article 18  |  9
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Of the many factors that affect the BOLD signal in Eq. 1, the com-
mon approach in calibrated fMRI has been not to include hematocrit 
(Buxton et al., 1998). At steady-state, CMRO2 calculation by calibrated 
fMRI assumes that volume (or discharge) hematocrit is unchanged, an 
assumption which has been partly confirmed by comparing kinetics 
of red blood cell and plasma volume changes (Herman et al., 2009b). 
However, dynamically different velocities of red blood cell and plasma 
compartments may become exaggerated in capillaries, which in turn 
could affect the flow (or tube) hematocrit (Pries et al., 1986). Thus, an 
important consideration for future calibrated fMRI studies is the pos-
sible involvement of transient hematocrit changes (Fahraeus, 1929) 
on the dynamic BOLD contrast, and which in turn may account for 
small deviations in the residual signals that have been observed.
conclusIon
The results discussed above show that comparing signal strength of 
measured neural (LFP, MUA) and hyperemic (BOLD, CBV, CBF) 
components, over a wide range of stimuli time epochs, shows 
strong neurometabolic and neurovascular couplings that subse-
quently lead to dynamic calibrated fMRI to be performed. In the 
rat brain, CMRO2 increases within 1 s of stimulus onset and even for 
single event the energy demand peaks to nearly the same value as 
that obtained for steady-state stimuli. The early increase in CMRO2 
suggests that the energy expended by neural activity is primarily 
generated through oxidative metabolism. Thus, we find no signifi-
cant mismatch between oxidative and non-oxidative energy con-
sumption at early times during dynamic changes in neural activity. 
Although CMRO2 transients appear slower than the actual neural 
responses, their coupling for events separated by less than 200 ms 
highlights the sensitivity of high magnetic field dynamic calibrated 
fMRI for high resolution mapping of oxidative energetics.
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for transient and steady-state events. The different components 
of Eq. 1 were linearly correlated with neural activity and further-
more the transfer functions of each of the components of Eq. 1 
were time invariant. Together, these findings imply that oxygen 
equilibrates quickly between tissue and blood pools and thus all 
points of the hyperemic phase carry nearly the same calibration 
in Eq. 1 in relation to neural activity. First, we had to experimen-
tally assess if linearity exists between each hyperemic component 
and neural activity. Here we used the strength of each signal type. 
Second, we tested the universality of the respective transfer func-
tions to accurately predict the measured responses. With linearity 
and time invariance demonstrated from the multi-modal data, we 
identified a BOLD component for transient CMRO2 changes, from 
single events to steady-state (Figure 5). The transfer functions (for 
BOLD, CBV, CBF) generated for short-lasting events accurately 
predicted the response to long-lasting events.
These findings for CMRO2 transients raise the issue of the early 
dip observed with a variety of methods, including recordings of tis-
sue pO2, optical imaging of deoxyhemoglobin, and/or BOLD signal. 
The prior studies suggest the possibility of even an earlier CMRO2 
increase (within the first 500–700 ms after stimulation onset). The 
early tissue pO2 dip has been observed in anesthetized rats and 
cats (Ances et al., 2001; Thompson et al., 2003). Although optical 
imaging of deoxyhemoglobin have reported the early dip (Malonek 
and Grinvald, 1996), some inconsistencies remain about its vis-
ibility (Jones et al., 2001; Lindauer et al., 2001). The early dip in 
the BOLD signal has been noted primarily in some human studies 
(Menon et al., 1995; Hu et al., 1997), but it remains unclear whether 
this observation is specific to humans because no rat (Silva et al., 
2000) or monkey (Logothetis et al., 2001) studies have reported 
the early dip, whereas some cat studies have reported the dip (Kim 
et al., 2000) and others have not (Jezzard et al., 1997). Moreover 
the early BOLD signal dip may be sensitive to blood pCO2 (Harel 
et al., 2002). Despite the fact that the magnitude of the dip is near 
detection threshold of most techniques, its observation remains 
a very important topic of research (Ances, 2004). Future fMRI 
sensitivity improvements (e.g., better RF coils) may allow meas-
urement of the early BOLD signal dip and earlier CMRO2 increases 
to be assessed.
Figure 5 | Measured LFP and calculated CMRO2 signals for short- and long-lasting stimuli. Convolution analysis of the universal transfer functions suggests 
linearity of the hyperemic responses with neural activity. Similar trends were observed with MUA (data not shown). Modified from results published in Sanganahalli 
et al. (2009) and Herman et al. (2009a).Frontiers in Neuroenergetics  www.frontiersin.org  August 2010  | Volume 2  | Article 18  |  10
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